Adenoviral-mediated Gene transduction of the hepatocyte growth factor (HGF) antagonist, NK4, suppresses peritoneal metastases of gastric cancer in nude mice

European Journal of Cancer

Volumn 40, Issue 14, 2004, Pages 2135-2142

  Ueda, Kentaro ^a   Iwahashi, Makoto ^a   Matsuura, Ichiro ^a   Nakamori, Mikihito ^a   Nakamura, Masaki ^a   Ojima, Toshiyasu ^a   Naka, Teiji ^a   Ishida, Koichiro ^a   Matsumoto, Kunio ^b   Nakamura, Toshikazu ^b   Yamaue, Hiroki ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY   (Japan)

Author keywords

Adenoviral vector; CDDP; Gastric cancer; Gene therapy; HGF antagonist; NK4; Peritoneal metastasis

Indexed keywords

BETA GALACTOSIDASE; BLOOD CLOTTING FACTOR 8; BUFFER; CISPLATIN; HEPATOCYTE GROWTH FACTOR ANTAGONIST; NK 4; PHOSPHATE; SCATTER FACTOR; UNCLASSIFIED DRUG;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASCITES; BLOOD VESSEL; CANCER CELL CULTURE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; FEMALE; GENE THERAPY; GENERAL CONDITION IMPROVEMENT; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; INOCULATION; MOUSE; NONHUMAN; NUDE MOUSE; PERITONEUM METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; STAINING; STOMACH CANCER; TREATMENT OUTCOME; TUMOR VOLUME;

ADENOVIRIDAE; ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CISPLATIN; COMBINED MODALITY THERAPY; HEPATOCYTE GROWTH FACTOR; MICE; MICE, NUDE; MICROCIRCULATION; MITOGENS; PERITONEAL NEOPLASMS; STOMACH NEOPLASMS; TRANSDUCTION, GENETIC;

EID: 4444267635     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2004.05.006     Document Type: Article

References (38)

1. Benevolo M., Mottolese M., Cosimelli M., et al. Diagnostic and prognostic value of peritoneal immunocytology in gastric cancer. J. Clin. Oncol. 16:1998;3406-3411
2. Koga S., Kaibara N., Iitsuka Y., Kudo H., Kimura A., Hiraoka H. Prognostic significance of intraperitoneal free cancer cells in gastric cancer patients. J. Cancer Res. Clin. Oncol. 108:1984;236-238
3. Katai H., Maruyama K., Sasako T., Okajima K., Kinoshita T., Naparkov A. Mode of recurrence after gastric cancer surgery. Dig. Surg. 11:1994;99-103
4. Hallissery M.T., Dunn J.A., Ward L.C., Allum W.H. The second British stomach cancer group trial of adjuvant radiotherapy or chemotherapy in respectable gastric cancer: five-year follow-up. Lancet. 343:1994;1309-1312
5. Nakamura T., Nawa K., Ichihara A. Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats. Biochem. Biophys. Res. Commun. 122:1984;1450-1459
6. Nakamura T., Nishizawa T., Hagiya M., et al. Molecular cloning and expression of human hepatocyte growth factor. Nature. 342:1998;440-443
7. Zarnegar R., Michalopoulos G.K. The many faces of hepatocyte growth factor: from hepatopoiesis to hematopoiesis. J. Cell Biol. 129:1995;1177-1180
8. Vande Woude G.F., Jeffers M., Cortner J., Alvord G., Tsarfaty I., Resau J. Met-HGF/SF: tumourigenesis, invasion and metastasis. Ciba. Found Symp. 212:1997;119-130
9. Stella M.C., Comoglio P.M. HGF: a multifunctional growth factor controlling cell scattering. Int. J. Biochem. Cell Biol. 31:1999;1357-1362
10. Matsumoto K., Namamura T. NK4 (HGF-antagonist/angiogenesis inhibitor) in cancer biology and therapeutics. Cancer Sci. 94:2003;321-327
11. Di Renzo M.F., Narsimhan R.P., Olivero M., et al. Expression of the Met/HGF receptor in normal and neoplastic human tissues. Oncogene. 6:1991;1997-2003
12. Kaji M., Yonemura Y., Harada S., Liu X., Terada I., Yamamoto H. Participation of c-met in the progression of human gastric cancers: anti-c-met oligonucleotides inhibit proliferation or invasiveness of gastric cancer cells. Cancer Gene. Ther. 3:1996;393-404
13. Maehara N., Matsumoto K., Kuba K., Mizumoto K., Tanaka M., Nakamura T. NK4, a four-kringle antagonist of HGF, inhibits spreading and invasion of human pancreatic cancer cells. Br. J. Cancer. 84:2001;864-873
14. Maemondo M., Narumi K., Saijo Y., et al. Targeting angiogenesis and HGF function using an adenoviral vector expressing the HGF antagonist NK4 for cancer therapy. Mol. Ther. 5:2002;177-185
15. Date K., Matsumoto K., Shimura H., Tanaka M., Nakamura T. HGF/NK4 is a specific antagonist for pleiotrophic actions of hepatocyte growth factor. FEBS Lett. 420:1997;1-6
16. Date K., Matsumoto K., Kuba K., Shimura H., Tanaka M., Nakamura T. Inhibition of tumour growth and invasion by a four-kringle antagonist (HGF/NK4) for hepatocyte growth factor. Oncogene. 17:1998;3045-3054
17. Hiscox S., Parr C., Nakamura T., Matsumoto K., Mansel R.E., Jiang W.G. Inhibition of HGF/SF-induced breast cancer cell motility and invasion by the HGF/SF variant, NK4. Breast Cancer Res. Treat. 59:2000;245-254
18. Parr C., Hiscox S., Nakamura T., Matsumoto K., Jiang W.G. NK4, a new HGF/SF variant, is an antagonist to the influence of HGF/SF on the motility and invasion of colon cancer cells. Int. J. Cancer. 85:2000;563-570
19. Kuba K., Matsumoto K., Date K., Shimura H., Tanaka M., Nakamura T. HGF/NK4, a four-kringle antagonist of hepatocyte growth factor, is an angiogenesis inhibitor that suppresses tumour growth and metastasis in mice. Cancer Res. 60:2000;6737-6743
20. Jeung H.C., Rha S.Y., Jang W.I., Noh S.H., Chung H.C. Treatment of advanced gastric cancer by palliative gastrectomy, cytoreductive therapy and postoperative intraperitoneal chemotherapy. Br. J. Surg. 89:2003;460-466
21. Yokozaki H. Molecular characteristics of eight gastric cancer cell lines established in Japan. Pathol. Int. 50:2000;767-777
22. Kuniyasu H., Yasui W., Kitadai Y., Yokozaki H., Ito H., Tahara E. Frequent amplification of the c-met gene in scirrhous type stomach cancer. Biochem. Biophys. Res. Commun. 189:1992;227-232
23. Kuniyasu H., Yasui W., Yokozaki H., Kitadai Y., Tahara E. Aberrant expression of c-met mRNA in human gastric carcinoma. Int. J. Cancer. 55:1993;72-75
24. Ueda K., Iwahashi M., Nakamori M., Nakamura M., Yamaue H., Tanimura H. Enhanced selective gene expression by adenovirus vector using Cre/loxP regulation system for human carcinoembryonic antigen-producing carcinoma. Oncology. 59:2000;255-265
25. Ueda K., Iwahashi M., Nakamori M., et al. Carcinoembryonic antigen-specific suicide gene therapy of cytosine deaminase/5-fluorocytosine enhanced by Cre/loxP system in the orthotopic gastric carcinoma model. Cancer Res. 61:2001;6158-6162
26. Miyake S., Makimura M., Kanegae Y., et al. Efficient generation of recombinant adenoviruses using adenovirus DNA-terminal protein complex and a cosmid bearing the full-length virus genome. Proc. Natl. Acad. Sci. 93:1996;1320-1324
27. Mori A., Arii S., Furutani M., et al. Soluble Flt-1 gene therapy for peritoneal metastases using HVJ-cationic liposomes. Gene. Ther. 7:2000;1027-1033
28. Saimura M., Nagai E., Mizumoto K., et al. Intraperitoneal injection of adenovirus-mediated NK4 gene suppresses peritoneal dissemination of pancreatic cancer cell line AsPC-1 in nude mice. Cancer Gene. Ther. 9:2002;799-806
29. Yashiro M., Chung Y.S., Inoue T., et al. Hepatocyte growth factor (HGF) produced by peritoneal fibroblasts may affect mesothelial cell morphology and promote peritoneal dissemination. Int. J. Cancer. 67:1996;289-293
30. Nakajima M., Sawada H., Yamada Y., et al. The prognostic significance of amplification and overexpression of c-met and c-erb B-2 in human gastric carcinoma. Cancer. 85:1999;1894-1902
31. Tomioka D., Maehara N., Kuba K., et al. Inhibition of growth, invasion, and metastasis of human pancreatic carcinoma cells by NK4 in an orthotopic mouse model. Cancer Res. 61:2001;7518-7524
32. Kuba K., Matsumoto K., Ohnishi K., Shiratsuchi T., Tanaka M., Nakamura T. Kringle 1-4 of hepatocyte growth factor inhibits proliferation and migration of human microvascular endothelial cells. Biochem. Biophys. Res. Commun. 279:2000;846-852
33. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat. Med. 1:1995;27-31
34. Tanaka T., Cao Y., Folkman J., Fine H.A. Viral vector-targeted antiangiogenic gene therapy utilizing an angiostatin complementary DNA. Cancer Res. 58:1998;3362-3369
35. Chen Q.-R., Kumar D., Stass S.A., Mixson A.J. Liposomes complexed to plasmids encoding angiostatin and endostatin inhibit breast cancer in nude mice. Cancer Res. 59:1999;3308-3312
36. Jeung H.C., Rha S.Y., Jang W.I., Noh S.H., Chung H.C. Treatment of advanced gastric cancer by palliative gastrectomy, cytoreductive therapy and postoperative intraperitoneal chemotherapy. Br. J. Surg. 89:2002;460-466
37. Tsujitani S., Fukuda K., Saito H., et al. The administration of hypotonic intraperitoneal cisplatin during operation as a treatment for the peritoneal dissemination of gastric cancer. Surgery. 131:2002;S98-104
38. Hagiwara A., Takahashi T., Kojima O., et al. Pharmacologic effects of cisplatin microspheres on peritoneal carcinomatosis in rodents. Cancer. 71:1993;844-850